Barbara Valsasina

Barbara Valsasina has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as the Head of the Antibody Drug Conjugate (ADC) portfolio and Head of the Biotechnology department at Nerviano Medical Sciences, part of NMS Group. Previously, Barbara held various roles at Nerviano Medical Sciences, including Protein Characterisation Group Leader and Senior Scientist, as well as positions at Pharmacia and Pfizer, where responsibilities included leading the Proteomics lab and the Protein Chemistry lab. Barbara completed a degree at Università degli Studi di Milano from 1983 to 1989, following secondary education at Liceo Classico G. Carducci Milano from 1978 to 1983.